Fuan Pharmaceuticals (300194.SZ) subsidiary received the registration certificate for Quetiapine Hydrochloride Tablets.

China Fortune Finance and Economics APP News, Fuan Pharmaceutical (300194.SZ) announced that its wholly-owned subsidiary Fuan Pharmaceutical Group Ningbo Tianheng Pharmaceutical Co., Ltd. (referred to as "Tianheng Pharmaceutical") recently received the drug registration certificate for Quetiapine Hydrochloride Tablets issued by the National Medical Products Administration. Quetiapine hydrochloride tablets are used in the treatment of depression and are effective for patients with or without anxiety.